Embedded Community-based Heart-Age Risk Education Trial in Cinese Primary Healthcare
E-CHARM
Effectiveness of an Embedded Community-based Heart-Age Risk Education Model (E-CHARM) in Improving Cardiovascular Risk Awareness and Health Behaviors Among Older Adults With Hypertension: a Randomized Controlled Trial
1 other identifier
interventional
600
1 country
1
Brief Summary
This study evaluates the effectiveness of a brief Heart Age-based risk education intervention embedded in routine primary care for older adults with hypertension in China. The intervention uses routine health check data to generate a personalized one-page Heart Age report, delivered by physicians during regular follow-up visits. The trial tests whether this approach improves risk awareness and self-management behavior without disrupting clinical workflow.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Jul 2025
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2025
CompletedFirst Posted
Study publicly available on registry
July 1, 2025
CompletedStudy Start
First participant enrolled
July 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2026
ExpectedJuly 20, 2025
July 1, 2025
3 months
June 9, 2025
July 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in cardiovascular disease (CVD) risk awareness
assessed using a 10-item CVD Knowledge Questionnaire adapted from the Chinese version of the Cardiovascular Disease Attitudes and Beliefs Questionnaire (ABCD-C) and the Heart Disease Fact Questionnaire (HDFQ). Each item is scored as 1 (correct) or 0 (incorrect/Don't know), yielding a total score range from 0 to 10. Higher scores indicate greater knowledge and awareness of CVD risk factors.
3 months
Secondary Outcomes (7)
Change in physical activity level
3 months
Change in dietary behavior: fruit intake
3 months
Change in dietary behavior: table salt use
3 months
Change in medication adherence
3 months
Implementation outcomes 1: Feasibility (intervention group only)
3 months
- +2 more secondary outcomes
Other Outcomes (8)
Change in systolic blood pressure
12 months
Change in diastolic blood pressure
12 months
Change in body mass index (BMI)
12 months
- +5 more other outcomes
Study Arms (2)
Usual Care (Control Group)
NO INTERVENTIONParticipants in this arm will receive standard hypertension management as per Chinese national guidelines, including regular follow-up with primary care physicians. They will not receive a Heart Age report or structured cardiovascular risk communication.
Heart Age Communication (Intervention Group)
EXPERIMENTALParticipants in this arm will receive a personalized Heart Age report based on their annual health check data (blood pressure, cholesterol, glucose, BMI, smoking). The report will be explained by the physician during the routine follow-up visit using a standardized script. The session lasts 3-5 minutes and is integrated into existing workflow.
Interventions
Participants in the intervention arm will receive a personalized one-page Heart Age report based on data from their government-funded annual health check. The report is delivered by trained physicians using a standardized communication script during a routine follow-up visit. The control group receives usual chronic disease care without structured risk communication.
Eligibility Criteria
You may qualify if:
- Adults aged ≥60 years
- Diagnosed with hypertension
- Completed their government-funded annual health check within the past 3 months
- Scheduled for a routine follow-up consultation within the enrollment window -Able to provide informed consent-
You may not qualify if:
- Diagnosed dementia or severe cognitive impairment
- Terminal illness
- Participation in another clinical intervention trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tinglin Community Health Center
Suzhou, Jiangsu, 215316, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guanzhou Wang
Duke University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2025
First Posted
July 1, 2025
Study Start
July 19, 2025
Primary Completion
October 20, 2025
Study Completion (Estimated)
July 20, 2026
Last Updated
July 20, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
IPD will not be made publicly available due to data protection regulations and privacy concerns under local Chinese health authority guidelines. However, de-identified aggregated data may be shared upon reasonable request for academic research purposes. Requests should be submitted to the corresponding author and will be reviewed by the study steering committee.